BLND
Blend Labs, Inc.
BLND has lower modeled downside risk, despite its lower overall score.
INTC
Intel Corporation
INTC has the edge over BLND overall, supported by stronger fundamentals and stronger modeled upside.
BLND Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Unavailable |
BLND's cash flow is currently healthy, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
BLND PE Valuation
BLND has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
BLND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BLND's earnings to grow and its profitability to improve, with its revenue holding steady.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
INTC has the edge over BLND on the outlook, with more favorable revenue expectations.
BLND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.04 | — |
| Q3 2024 | -$0.33 | +$0.64 |
| Q2 2024 | -$0.48 | +$0.88 |
| Q1 2024 | -$0.57 | +$2.67 |
| Q4 2023 | -$0.76 | +$2.52 |
BLND has the stronger earnings trend. Trailing diluted EPS is down 116% for BLND versus INTC down 24,000%.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
BLND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | +0.2% |
| Q2 2026 | $33.8M | +7.3% |
| Q1 2026 | $30.8M | +15% |
| Q4 2025 | $32.4M | -22% |
| Q3 2025 | $32.9M | -27% |
| Q2 2025 | $31.5M | -22% |
| Q1 2025 | $26.8M | -23% |
| Q4 2024 | $41.4M | +15% |
BLND's revenue fell from its 2021 peak and has held roughly level since: $33M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +6.9 points |
| Q2 2026 | -4.7% | +10 points |
| Q1 2026 | -16% | +12 points |
| Q4 2025 | -11% | -6.7 points |
| Q3 2025 | -15% | +15 points |
| Q2 2025 | -15% | +18 points |
| Q1 2025 | -29% | +32 points |
| Q4 2024 | -4.3% | +56 points |
BLND's operating margin was −8% last quarter, up 6.9 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over BLND on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over BLND on profitability, with a higher operating margin.
BLND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94K | +$5.9M |
| Q2 2026 | $7.1M | +$17.2M |
| Q1 2026 | $6.2M | -61% |
| Q4 2025 | -$21K | +$7.1M |
| Q3 2025 | -$5.8M | -$4.4M |
| Q2 2025 | -$10.1M | -$1.6M |
| Q1 2025 | $15.8M | +$21.6M |
| Q4 2024 | -$7.2M | +$13.6M |
BLND's free cash flow has turned positive after six years mostly in the red: $13M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over BLND on cash flow, with more consistent year-over-year improvement.
BLND Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.2% | -18.3M shares |
| 1 year | -8.4% | -21.9M shares |
| 3 years | -2.8% | -6.9M shares |
| 5 years | +8.1% | +17.7M shares |
| Available history | +8.1% | +17.7M shares |
BLND has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $20.4M |
| Q1 2026 | $16.8M |
| Q4 2025 | $15.7M |
| Q3 2025 | $5M |
| Q2 2025 | $1.6M |
| Q1 2025 | $2.6M |
| Q4 2021 | $110,000 |
BLND spent $53M buying back its own shares over the past year.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
BLND Net Leverage
BLND's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
BLND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 19.4 | Oversold |
BLND's weekly RSI is 38 (neutral) and its Stochastic is 19 (oversold).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
BLND PE vs Technology Sector
BLND has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
BLND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 1.9% above |
| 20 week MA | $1.37 | 22% below |
| 50 week MA | $1.77 | 40% below |
| 100 week MA | $2.63 | 59% below |
| 200 week MA | $2.44 | 56% below |
BLND has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 56% below its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over BLND on trend strength, trading above more of its moving averages.
BLND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.9 | $7.53 | -64% |
| 2022 | $7.53 | $1.22 | -84% |
| 2023 | $1.22 | $2.55 | +109% |
| 2024 | $2.55 | $4.29 | +68% |
| 2025 | $4.29 | $3.05 | -29% |
| 2026 YTD | $3.05 | $1.07 | -65% |
BLND's yearly returns have swung widely, from +109% in 2023 to −84% in 2022. It's down 65% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over BLND on returns for 2026, with the stronger performance.